A detailed history of Cx Institutional transactions in Illumina, Inc. stock. As of the latest transaction made, Cx Institutional holds 1,668 shares of ILMN stock, worth $238,440. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,668
Holding current value
$238,440
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$105.28 - $135.9 $175,607 - $226,681
1,668 New
1,668 $217,000
Q1 2024

Apr 15, 2024

BUY
$127.73 - $147.2 $4,598 - $5,299
36 Added 2.25%
1,636 $224,000
Q4 2023

Jan 12, 2024

BUY
$92.79 - $142.53 $148,464 - $228,048
1,600 New
1,600 $222,000
Q3 2022

Nov 04, 2022

BUY
$177.23 - $227.44 $1.87 Million - $2.4 Million
10,539 Added 12852.44%
10,621 $2.03 Million
Q2 2022

Aug 02, 2022

BUY
$181.58 - $368.0 $14,889 - $30,176
82 New
82 $15,000
Q4 2021

Jan 18, 2022

SELL
$347.28 - $421.83 $105,225 - $127,814
-303 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $2,433 - $3,149
6 Added 2.02%
303 $123,000
Q2 2021

Aug 04, 2021

BUY
$372.84 - $481.5 $35,419 - $45,742
95 Added 47.03%
297 $141,000
Q1 2021

Apr 15, 2021

BUY
$361.28 - $504.76 $6,864 - $9,590
19 Added 10.38%
202 $78,000
Q4 2020

Jan 12, 2021

BUY
$292.7 - $370.96 $31,611 - $40,063
108 Added 144.0%
183 $68,000
Q3 2020

Oct 13, 2020

SELL
$268.51 - $400.74 $4,833 - $7,213
-18 Reduced 19.35%
75 $23,000
Q2 2020

Aug 06, 2020

BUY
$256.46 - $373.01 $8,976 - $13,055
35 Added 60.34%
93 $34,000
Q1 2020

Apr 29, 2020

BUY
$209.2 - $335.53 $4,811 - $7,717
23 Added 65.71%
58 $16,000
Q4 2019

Jan 21, 2020

BUY
$288.29 - $335.49 $9,225 - $10,735
32 Added 1066.67%
35 $12,000
Q3 2019

Oct 10, 2019

SELL
$266.84 - $378.23 $7,738 - $10,968
-29 Reduced 90.63%
3 $1,000
Q1 2019

Apr 03, 2019

BUY
$272.57 - $321.18 $8,722 - $10,277
32 New
32 $10,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.